Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study.
Barrows cards
Renal transplantation
adherence
knowledge improvement
pharmacist-led intervention
Journal
Therapeutic advances in chronic disease
ISSN: 2040-6223
Titre abrégé: Ther Adv Chronic Dis
Pays: United States
ID NLM: 101532140
Informations de publication
Date de publication:
2021
2021
Historique:
received:
17
01
2021
accepted:
03
03
2021
entrez:
19
4
2021
pubmed:
20
4
2021
medline:
20
4
2021
Statut:
epublish
Résumé
To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort. We conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG), At visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3% Our intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.
Identifiants
pubmed: 33868624
doi: 10.1177/20406223211005275
pii: 10.1177_20406223211005275
pmc: PMC8024450
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20406223211005275Informations de copyright
© The Author(s), 2021.
Déclaration de conflit d'intérêts
Conflict of interest statement: The authors declare that there is no conflict of interest.
Références
Am J Transplant. 2013 Sep;13(9):2364-73
pubmed: 23819827
Transpl Int. 2005 Oct;18(10):1121-33
pubmed: 16162098
Prog Transplant. 2006 Sep;16(3):206-14
pubmed: 17007154
J Adv Nurs. 2016 Apr;72(4):754-8
pubmed: 26749272
BMC Nephrol. 2011 Jul 22;12:35
pubmed: 21777480
Nephrol Dial Transplant. 2015 May;30(5):752-61
pubmed: 24950938
Int J Clin Pharm. 2017 Jun;39(3):582-593
pubmed: 28374343
Transplantation. 2013 Jan 27;95(2):326-32
pubmed: 23149477
Am J Transplant. 2015 Nov;15(11):2921-30
pubmed: 26096305
Syst Rev. 2017 Nov 29;6(1):236
pubmed: 29187249
Am J Transplant. 2009 Nov;9(11):2597-606
pubmed: 19843035
Transpl Int. 2009 Aug;22(8):780-97
pubmed: 19386076
Transplantation. 2016 Nov;100(11):2479-2485
pubmed: 26703349
J Am Soc Nephrol. 2017 Nov;28(11):3353-3362
pubmed: 28729289
Am J Transplant. 2009 Nov;9(11):2497-504
pubmed: 19681814
Am J Transplant. 2007 Dec;7(12):2704-11
pubmed: 17868065
Transplantation. 2019 Mar;103(3):565-572
pubmed: 29965952
Br J Clin Pharmacol. 2009 Oct;68(4):588-98
pubmed: 19843062
Pharmacoeconomics. 2004;22(18):1217-34
pubmed: 15606228
Health Expect. 2015 Oct;18(5):1270-81
pubmed: 23786500
J Am Soc Nephrol. 2017 Aug;28(8):2290-2301
pubmed: 28630231
Liver Transpl. 2015 Jan;21(1):22-8
pubmed: 25312406
J Am Pharm Assoc (2003). 2015 Jul-Aug;55(4):e354-61; quiz e362-3
pubmed: 26161493
Transplantation. 2004 Mar 15;77(5):769-76
pubmed: 15021846